Authorized since the end of December in the EU, following a positive recommendation from the European Medicines Agency (EMA) on December 20, Nuvaxovid should soon join the vaccine arsenal once morest Covid-19 in France. The first doses of this vaccine from the American laboratory Novavax, the fifth anti-Covid authorized in Europe, should be delivered to France ” from the end of January “, According to a spokesperson for the Ministry of Solidarity and Health.